Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$521M |
| 2 |
Becton Dickinson
BDX
|
+$411M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
IBM
IBM
|
+$305M |
| 5 |
Philip Morris
PM
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$455M |
| 2 |
NetEase
NTES
|
+$451M |
| 3 |
Medtronic
MDT
|
+$398M |
| 4 |
NVIDIA
NVDA
|
+$348M |
| 5 |
Netflix
NFLX
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.06% |
| 2 | Technology | 13.71% |
| 3 | Financials | 10.21% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HBP
2001
DELISTED
Huttig Building Products, Inc.
HBP
| $3.64M | ﹤0.01% |
547,800
-53,100
| -9% | -$357K |
|
2002
World Acceptance Corp
WRLD
$840M
| $3.63M | ﹤0.01% |
45,000
+19,575
| +77% | +$1.57M |
|
2003
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.08B
| $3.62M | ﹤0.01% |
+121,000
| New | +$3.64M |
|
|
XBKS
2004
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
| $3.62M | ﹤0.01% |
107,126
-26,400
| -20% | -$876K |
|
|
CALA
2005
DELISTED
Calithera Biosciences, Inc
CALA
| $3.62M | ﹤0.01% |
21,648
+13,673
| +171% | +$3.5M |
|
2006
AstraZeneca
AZN
$266B
| $3.6M | ﹤0.01% |
+51,950
| New | +$3.5M |
|
2007
Virtus Investment Partners
VRTS
$1.09B
| $3.59M | ﹤0.01% |
31,229
+19,000
| +155% | +$2.23M |
|
|
MGIC
2008
DELISTED
Magic Software Enterprises
MGIC
| $3.59M | ﹤0.01% |
428,651
+36,599
| +9% | +$316K |
|
|
RSX
2009
DELISTED
VanEck Russia ETF
RSX
| $3.59M | ﹤0.01% |
+169,200
| New | +$3.71M |
|
2010
Air T
AIRT
$75.4M
| $3.59M | ﹤0.01% |
217,950
| – | – |
|
2011
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.5B
| $3.59M | ﹤0.01% |
+14,500
| New | +$3.43M |
|
2012
Veracyte
VCYT
$4.77B
| $3.59M | ﹤0.01% |
549,300
-5,459
| -1% | -$40.6K |
|
2013
Oppenheimer Holdings
OPY
$1.19B
| $3.58M | ﹤0.01% |
133,500
+66,400
| +99% | +$1.56M |
|
|
I
2014
DELISTED
INTELSAT S. A.
I
| $3.58M | ﹤0.01% |
1,055,355
+461,155
| +78% | +$2.06M |
|
|
VRN
2015
DELISTED
Veren
VRN
| $3.57M | ﹤0.01% |
468,817
-336,083
| -42% | -$2.53M |
|
2016
LGI Homes
LGIH
$1.33B
| $3.56M | ﹤0.01% |
+47,500
| New | +$3.02M |
|
|
NWY
2017
DELISTED
New York & Co Inc
NWY
| $3.54M | ﹤0.01% |
1,237,200
+72,800
| +6% | +$157K |
|
2018
Agilysys
AGYS
$3.04B
| $3.54M | ﹤0.01% |
288,000
-20,752
| -7% | -$254K |
|
2019
STRATTEC Security
STRT
$369M
| $3.54M | ﹤0.01% |
81,165
-2,300
| -3% | -$100K |
|
2020
CRH
CRH
$64.1B
| $3.53M | ﹤0.01% |
97,800
-171,500
| -64% | -$6.14M |
|
2021
IES Holdings
IESC
$11.4B
| $3.53M | ﹤0.01% |
204,632
-47,400
| -19% | -$855K |
|
|
BPY
2022
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $3.53M | ﹤0.01% |
159,114
+85,600
| +116% | +$1.96M |
|
2023
Nicolet Bankshares
NIC
$3.57B
| $3.52M | ﹤0.01% |
64,315
+6,315
| +11% | +$364K |
|
|
TRQ
2024
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $3.52M | ﹤0.01% |
102,584
+95,054
| +1,262% | +$2.99M |
|
2025
Calumet Specialty Products
CLMT
$3.81B
| $3.52M | ﹤0.01% |
456,700
-58,500
| -11% | -$488K |
|
Similar funds
Renaissance Technologies's Q4 2017 Portfolio in Review
As of Q4 2017, Renaissance Technologies held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Renaissance Technologies's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
- Renaissance Technologies added most to ExxonMobil in Q4 2017, an estimated $521M increase.
- Renaissance Technologies's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
- Renaissance Technologies fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
- Renaissance Technologies's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
- Renaissance Technologies opened 521 new positions and closed 386 in Q4 2017.
- Renaissance Technologies's portfolio value rose 6.7% quarter-over-quarter to $90.7B.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.